Mirion Technologies MIR Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Total revenues by Business | ||||||
| Medical Segment | $314.3M+1.1% | $310.8M-1.0% | $313.9M+1.4% | $309.5M+2.7% | $301.5M+0.6% | |
| Nuclear & Safety | $666.7M+8.5% | $614.6M+4.5% | $588.4M+2.1% | $576.5M+1.4% | $568.7M+1.4% | |
| Segment Income From Operations by Business | ||||||
| Medical Segment | $48M+2.3% | $46.9M+16.7% | $40.2M+20.0% | $33.5M+21.4% | $27.6M+23.8% | |
| Nuclear & Safety | $100.3M-0.8% | $101.1M+6.3% | $95.1M+7.5% | $88.5M+0.6% | $88M+11.5% | |
| Adjusted Income Loss From Operations by Business | ||||||
| Medical Segment | -$109.9M-0.8% | -$109M+2.7% | -$112M-0.8% | -$111.1M-3.2% | -$107.7M+0.9% | |
| Nuclear & Safety | -$354.3M-9.4% | -$324M-3.3% | -$313.5M-1.6% | -$308.7M-2.3% | -$301.7M-0.4% | |
| Other segment items by Business | ||||||
| Medical Segment | $156.4M+1.0% | $154.9M-4.2% | $161.7M-1.9% | $164.9M-0.8% | $166.2M-1.5% | |
| Nuclear & Safety | $212.1M+11.9% | $189.5M+5.4% | $179.8M+0.3% | $179.3M+0.2% | $179M-1.5% | |
| D&A by Business | ||||||
| Medical Segment | $65.3M-0.3% | $65.5M-1.7% | $66.6M-2.9% | $68.6M-3.2% | $70.9M-2.9% | |
| Nuclear & Safety | $79M+10.2% | $71.7M+3.3% | $69.4M-2.4% | $71.1M-3.4% | $73.6M-4.0% | |
| CapEx by Business | ||||||
| Medical Segment | $19.2M-5.0% | $20.2M+3.6% | $19.5M-7.6% | $21.1M-12.4% | $24.1M-13.9% | |
| Nuclear & Safety | $20M+7.0% | $18.7M-5.6% | $19.8M+7.6% | $18.4M+5.1% | $17.5M-1.1% | |
| Translation adjustment by Business | ||||||
| Medical Segment | $0— | $0— | $0— | $0— | $0— | |
| Nuclear & Safety | $23.8M-49.1% | $46.8M+19.1% | $39.3M+17.3% | $33.5M+1,181% | -$3.1M+85.9% | |
| Goodwill by Business | ||||||
| Medical Segment | $2.54B0.0% | $2.54B0.0% | $2.54B— | —— | —— | |
| Nuclear & Safety | $3.36B+14.3% | $2.94B+17.9% | $2.49B— | —— | —— | |
| Total revenues by Product | ||||||
| Cancer care | $243.4M+1.8% | $239.1M-0.9% | $241.2M+2.1% | $236.3M+2.7% | $230.1M+0.9% | |
| Labs and research | $123.7M+1.2% | $122.2M-2.1% | $124.8M-1.1% | $126.2M+0.6% | $125.5M-4.7% | |
| Other | $112.2M-0.7% | $113M+0.1% | $112.9M+2.5% | $110.1M+0.9% | $109.1M-3.3% | |
| Total cost of revenues by Product | ||||||
| Product | $407.8M+8.3% | $376.6M+3.0% | $365.6M+1.0% | $361.9M+3.0% | $351.4M+0.8% | |
| Service | $111.6M+1.3% | $110.2M-1.0% | $111.3M+0.9% | $110.3M+0.2% | $110.1M-2.0% | |
| Total revenues by Geography | ||||||
| Asia Pacific | $14.5M-7.1% | $15.6M+9.9% | $14.2M+2.2% | $13.9M+7.8% | $12.9M0.0% | |
| Europe | $340.1M+3.8% | $327.7M+2.9% | $318.5M+3.4% | $308.1M+1.5% | $303.4M-0.8% | |
| North America | $626.4M+7.6% | $582.1M+2.2% | $569.6M+1.0% | $564M+1.8% | $553.9M+2.2% | |
| Property, plant, and equipment, net by Geography | ||||||
| Asia Pacific | $400K0.0% | $400K0.0% | $400K— | —— | —— | |
| Europe | $241.9M+1.0% | $239.6M+2.9% | $232.9M— | —— | —— | |
| North America | $371.6M+0.6% | $369.5M+0.5% | $367.6M— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Mirion Technologies break its business down?
- Mirion Technologies (MIR) reports total revenues by business across 2 parts — Medical Segment and Nuclear & Safety. Each is extracted from the segment footnotes and tracked over time.
- Where does Mirion Technologies's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Mirion Technologies's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.